In honor of the impending New Year … we have 38 papers for you in just one month! There’s some sophisticated work here – innovative epidemiology, interventions, and reviews of overdose. We’ve come a long way from the 1990s, but clearly not quickly enough for the dynamic urgency of this issue. 1) Safety andRead More
PubMed Update July 2016
11 papers this month, including an announcement that naloxone is now over-the-counter in Australia. 1) Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Harm Reduct J. 2016 Jul 26;13(1):24. doi: 10.1186/s12954-016-0113-2. Comments: Less than half knewRead More
PubMed Update March 2016
23 this month. 1) Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. McDonald R, Strang J. Addiction. 2016 Mar 30. doi: 10.1111/add.13326. [Epub ahead of print] Review. Comments: Take-home naloxone meets all Bradford Hill criteria for causality in reducing opioid overdose mortality. Incidence of fatality among overdoses in the setting ofRead More
PubMed Update February 2016
Ten articles for February 2016. 1) As opioid overdose deaths reach record highs, call for systematic changes grows louder. [No authors listed] ED Manag. 2016 Feb;28(2):13-9. Comments: Review of the new CDC opioid prescribing guidelines. 2) Australia reschedules naloxone for opioid overdose. Lenton SR, Dietze PM, Jauncey M. Med J Aust. 2016 Mar 7;204(4):146-7. No abstract available. Comments: Naloxone canRead More
PubMed Update August 2015
Sixteen in August. Back on schedule (thanks to jetlag). 1) Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies. Hawk KF, Vaca FE, D’Onofrio G. Yale J Biol Med. 2015 Sep 3;88(3):235-245. eCollection 2015 Sep. Review. Comment: Can’t access full article. Appears to be a review of harm reduction strategies for opioid overdose prevention.Read More
PubMed Update May/June 2014
25 papers in two months. Anyone want to help with this? 1) Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial. Sabzghabaee AM, Eizadi-Mood N, Yaraghi A, Zandifar S. Arch Med Sci. 2014 May 12;10(2):309-14. doi: 10.5114/aoms.2014.42584. Epub 2014 May 13. PMID: 24904666 [PubMed] Free PMC Article Comments: More data toRead More
PubMed Update June 2013
13 new papers this month, from drug development to naloxone programming, epidemiology to practice management, toxicology to supply side drug control. 1) Illicit drug overdose – Prevalence and acute management. Li W, Gunja N. Aust Fam Physician. 2013 Jul;42(7):481-5. Comment: Unable to access. Appears to be a general review of managing illicit drug toxicities. 2)Read More